Effects of p53 mutation on tumor progression: recent insights from mouse tumor models
Data up to Jan 2025
Total Citations Per Year
Abstract
References (53)
A genetic model for colorectal tumorigenesis
1990 • 11,800 citations
WAF1, a potential mediator of p53 tumor suppression
1993 • 8,360 citations
The Clonal Evolution of Tumor Cell Populations
1976 • 6,310 citations
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
1993 • 5,680 citations
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 • 3,092 citations
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 • 2,969 citations
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 • 2,911 citations
Thymocyte apoptosis induced by p53-dependent and independent pathways
1993 • 2,322 citations
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
1991 • 2,127 citations
Definition of a consensus binding site for p53
1992 • 2,000 citations
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 • 1,460 citations
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
1992 • 1,358 citations
Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
1992 • 1,117 citations
Oncogenic forms of p53 inhibit p53-regulated gene expression
1992 • 933 citations
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
1994 • 883 citations
Gain of function mutations in p53
1993 • 876 citations
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
1993 • 875 citations
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
1990 • 801 citations
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
1988 • 745 citations
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
1992 • 735 citations
A transcriptionally active DNA-binding site for human p53 protein complexes.
1992 • 729 citations
A p53-Dependent Mouse Spindle Checkpoint
1995 • 668 citations
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
1994 • 617 citations
Wild-type p53 activates transcription in vitro
1992 • 609 citations
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
1991 • 544 citations
Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice
1993 • 537 citations
In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
1993 • 471 citations
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
1993 • 465 citations
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
1994 • 406 citations
Growth factor modulation of p53-mediated growth arrest versus apoptosis.
1995 • 377 citations
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
1989 • 360 citations
Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations
1994 • 333 citations
Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
1994 • 315 citations
Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.
1994 • 310 citations
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
1994 • 290 citations
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
1995 • 280 citations
Transcriptional activation by p53 correlates with suppression of growth but not transformation
1994 • 237 citations
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient mice
1995 • 233 citations
Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
1991 • 230 citations
Fibroblast Growth Factor
1990 • 173 citations
Increased p53 protein content of colorectal tumours correlates with poor survival
1992 • 147 citations
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.
1994 • 142 citations
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
1994 • 140 citations
Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.
1995 • 138 citations
Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
1991 • 131 citations
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
1995 • 114 citations
p53 abnormalities and genomic instability in primary human breast carcinomas.
1995 • 108 citations
Testing the Role of p53 in the Expression of Genetic Instability and Apoptosis in Ataxia-telangiectasia
1994 • 101 citations
High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA Aneuploidy
1992 • 101 citations
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
1995 • 94 citations
Induction of apoptosis by tumor suppressor genes and oncogenes
1995 • 81 citations
GERMLINE p53 MUTATIONS AND HERITABLE CANCER
1994 • 78 citations
Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
1993 • 40 citations